LPCAT1 and coronary artery disorder: However, a notable increase in the percentage of participants carrying the LPCAT1 haplotype 3 (H-3) could be observed across the three groups, this rose from 13.33% in controls, to 19.28% in the high-risk group, and then to 27.21% in the CAD group (χ2 of p = 0.02).